英语翻译Adimab is changing the discovery,maturation and production of therapeutic human antibodies.By integrating all aspects of antibody discovery and developing sophisticated screening methods,Adimab can rapidly discover high affinity antibodie

英语翻译Adimab is changing the discovery,maturation and production of therapeutic human antibodies.By integrating all aspects of antibody discovery and developing sophisticated screening methods,Adimab can rapidly discover high affinity antibodie
英语翻译
Adimab is changing the discovery,maturation and production of therapeutic human antibodies.By integrating all aspects of antibody discovery and developing sophisticated screening methods,Adimab can rapidly discover high affinity antibodies that also behave well in a formulation and manufacturing context.Our proprietary library design and presentation technology allows us to discover full-length human antibodies with broad epitope coverage,high affinity and therapeutic relevance faster than any current technology.
Polaris Venture Partners is a partnership of experienced private equity investors,operating executives and entrepreneurs.The firm's mission is to identify,invest in and partner with seed,early stage,and middle market businesses with exceptional promise and help them grow into market-leading companies.The firm has over $3 billion under management,more than 20 investment professionals,and current investments in more than 75 companies.
需要人工翻译的！

英语翻译Adimab is changing the discovery,maturation and production of therapeutic human antibodies.By integrating all aspects of antibody discovery and developing sophisticated screening methods,Adimab can rapidly discover high affinity antibodie
Adimab正在改变着治疗性人类抗体的发现成果、成熟度和产品.通过综合有关抗体的发现和长时间发展的拍摄技术的所有方面,Adimab 能够迅速的找到高相似度抗体,并在规划及工业生产上表现很好.我们所有的命令集设计和陈述的技术使得我们能够找到带有宽覆盖范围的人类抗原决定簇,高相似度,并且别现金的技术更快适应治疗.
Polaris Venture Partners是一个资深的私人投资人,操作主管和企业家.公司的目标是认同投资给处于初级阶段的和作者,中型市场额外承诺,并帮助他们成长为引领市场的公司.公司拥有超过30亿美元资金,超过20个投资专家,并在最近投资了超过75个公司

adimab正在改变发现，成熟和生产治疗人类抗体。通过整合各方面的抗体发现与发展尖端筛选方法， adimab可以迅速地发现高亲和力抗体，也管好自己，在配方和制造。我们的专有库设计和演示技术使我们能够发现完整长度的人类抗体与抗原表位的广泛报导，高亲和力和治疗的相关速度比现有的任何技术。
北极星合资伙伴的是合作伙伴的经验丰富的私人股本投资者，经营管理层和企业家队伍。该公司的使命，就是要确定，...

全部展开

adimab正在改变发现，成熟和生产治疗人类抗体。通过整合各方面的抗体发现与发展尖端筛选方法， adimab可以迅速地发现高亲和力抗体，也管好自己，在配方和制造。我们的专有库设计和演示技术使我们能够发现完整长度的人类抗体与抗原表位的广泛报导，高亲和力和治疗的相关速度比现有的任何技术。
北极星合资伙伴的是合作伙伴的经验丰富的私人股本投资者，经营管理层和企业家队伍。该公司的使命，就是要确定，投资和合作伙伴，与种子，早期阶段，中级市场企业与特殊承诺，并帮助他们成长为具有市场领先地位的公司。该公司有超过30亿美元的管理下，已有20多位专业投资人员，而当前的投资超过75家公司。

收起

Polaris Venture Partners is a partnership of experienced private equity investors, operating executives and entrepreneurs. The firm's mission is to identify, invest in and partner with seed, early sta...

全部展开

Polaris Venture Partners is a partnership of experienced private equity investors, operating executives and entrepreneurs. The firm's mission is to identify, invest in and partner with seed, early stage, and middle market businesses with exceptional promise and help them grow into market-leading companies. The firm has over $3 billion under management, more than 20 investment professionals, and current investments in more than 75 companies
北极星风投是一个是由私人投资者，经营人员和企业家组成的合伙制公司。公司致力于辨别，投资，参与种子，初创，中等有潜力的公司，帮助其发展成为市场领先的企业。公司掌管30亿美元，超过20个投资专业，并在最近投资了超过75个项目。

收起